Joe Biden, AP Images
June 1, 2021 07:01 AM EDTUpdated 07:17 AM
FDA+

Biden 2022 bud­get wish list calls for Medicare ne­go­ti­a­tions on drug prices, new $6.5B NIH agency

Zachary Brennan

Senior Editor

Pres­i­dent Joe Biden late last week re­leased his FY 2022 bud­get plan, call­ing for Medicare to ne­go­ti­ate pay­ment for cer­tain high-cost drugs, in ad­di­tion to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bio­phar­ma be­gins to con­tem­plate an RFK Jr.-in­flu­enced FDA if Trump wins

No­vo Nordisk claims late-stage MASH vic­to­ry, con­tin­u­ing GLP-1's ex­pan­sion

Ex­clu­sive: Blood stem cell ther­a­py mak­er Garu­da gets new CEO, adds $47M

Bio­gen brings in med­ical chief as CFO plans re­tire­ment; Macro­Gen­ics CEO an­nounces de­par­ture

Ex­clu­sive: Women’s health uni­corn Maven Clin­ic cuts 10% of its work­force weeks af­ter rais­ing $125M

Q&A: Jade CEO talks about re­verse merg­er and IgAN drugs

A service from the Financial Times